Are you and/or your team attending the DIA next month? Stop by our booth, D5, and talk to one of our team about how we can support you to optimise your path to approval.
We know that the path to drug approval is littered with pitfalls which can lead to unnecessary delays getting your medicine to the people who need it the most – the patients.
Working together we can:
- Accelerate your drug development program to reduce your time to approval
- Optimise the management of the regulatory process to provide accurate and predictable outcomes
- Reduce your risks and increase the probability of gaining Market Authorization
In addition to our team at the booth we have some great speakers sharing their knowledge in different forums throughout the conference, see below:
Dr Mira Pavlovic – HTA Expert, NDA Regulatory Advisory Board member
Hub 1 #CH104 | Thurs, 7th February – 09:15
Patient-reported, Patient-relevant, Patient-centred outcomes: definitions, roles and importance for health technology assessment
Brian Edwards – Principal Consultant, Pharmacovigilance & Drug Safety
Hub 2 | Tues, 5th February – 13:00
CAST analysis of UK pregnancies reported after isotretinoin administration
Prof. Beatriz Silva Lima – Non Clinical Expert, NDA Regulatory Advisory Board member
Session – #DL04 | Wed, 18th March
Industry – Regulator Dialogue: Tailor-made Regulatory Guidance for Non-clinical to Clinical Development
Panelist: How has the New EU Guideline Changed the Conduct of First in Human Trials in Europe
Speaker: Beatriz Silva Lima
Session – #S0512/0612 | Thu, 19th March
Panoramic Hall – Regulatory Science Training and Network in European Academia
Session Chair: Beatriz Silva Lima
Click here to download the Preliminary Programme.
Pre-book a meeting with one our team
To book a meeting contact firstname.lastname@example.org we look forward to seeing you at the in Brussels!